CALC CalciMedica, Inc.
Company Analysis
Latest News
🟢 CalciMedica is trading 5.14% up today after Stonepine Capital expanded stake to 6.00%
CalciMedica is trading 5.14% up at $2.25 after Stonepine Capital Management expanded its position on August 19, 2026, bringing ownership to 6.00%. - The...
🟢 CalciMedica is trading 5.1% up in pre-market after Stonepine Capital Management expands stake
CalciMedica is trading at $2.25, up 5.14% in pre-market following significant post-split volatility. * Stonepine Capital Management expanded its stake in...
🟢 CalciMedica is trading 12.53% up in after-hours trading after completing a 1-for-5 reverse stock split
CalciMedica is trading $2.41 (+12.53%) after completing a 1-for-5 reverse stock split. • The reverse split became effective at 5:00 p.m. ET on August 28,...
🟢 CalciMedica is trading 6.54% up today in after-hours trading following 1-for-5 reverse stock split
CalciMedica is trading 6.54% up now at $2.28 in after-hours trading following its 1-for-5 reverse stock split. - Effective 5:00 p.m. ET, August 28, 2026. -...
🔴 CalciMedica is trading 5.9% down today after a 1-for-5 reverse stock split
CalciMedica is trading 5.9% down at $2.19 after the 1-for-5 reverse stock split became effective at 5:00 p.m. ET on August 28, 2026. - Split-adjusted trading...
🔴 CalciMedica is trading 6% down in pre-market after its 1-for-5 reverse stock split took effect
CalciMedica is trading at $2.18 (-6.12%) after its 1-for-5 reverse stock split became effective after the August 28, 2026 close at 5:00 p.m. ET; the reverse...
🔴 CalciMedica is trading 6.1% down today after announcing a 1-for-5 reverse stock split
CalciMedica is trading at $0.44, down 6.1%, after announcing a 1-for-5 reverse stock split. • The announcement followed a 20.00% decline on August 27; company...
CalciMedica Announces 1-for-5 Reverse Stock Split and Reduction of Authorized Shares
CalciMedica, Inc. filed a Certificate of Amendment to enact a 1-for-5 reverse stock split of its common stock, effective at 5:00 p.m. ET on August 28, 2026....
CalciMedica's Reverse Stock Split Buys Time on Nasdaq, but Can a Sub-Dollar Biotech Survive the Signal It Sends?
Shares of CalciMedica (CALC) tumbled 14.9% to $0.50 on August 27, 2026, after the clinical-stage biotech announced a one-for-five reverse stock split — a move...
🔴 CalciMedica is trading 14.89% down today after announcing a reverse split to restore Nasdaq compliance
CalciMedica is trading at $0.50 (-14.89%) after announcing a one-for-five reverse stock split intended to restore compliance with Nasdaq’s minimum bid-price...
🔴 CalciMedica is trading 9.74% down today as immediate catalyst remains unclear
CalciMedica is trading 9.74% down now at $0.53 after no verified company-specific announcement dated August 26 or August 27 was identified. - The latest...
🔴 CalciMedica is trading 9.79% down in pre-market; no verified company-specific catalyst identified
CalciMedica is trading 9.79% down at $0.53, with no verified company-specific catalyst identified. - It closed at $0.59 on August 26, 2026; no verified...
🟢 CalciMedica is trading 5.53% up in after-hours trading with no verified new company announcement
CalciMedica is trading 5.53% up in after-hours trading at $0.62 after closing at $0.59 on August 26, 2026, with no verified new company-specific catalyst. -...
🟢 CalciMedica, Inc. is trading 5.03% up
CALC is trading at $0.58, up 5.03%.
🟢 CalciMedica is trading 5% up in pre-market after Guggenheim's Buy rating and $9.00 target
CalciMedica is trading 5.12% up in pre-market at $0.60 after Guggenheim initiated coverage with a Buy rating and a $9.00 price target on August 20, 2026. -...
🟢 CalciMedica is trading 6.65% up in after-hours trading after Guggenheim's Buy initiation
CalciMedica is trading 6.65% up at $0.62 after Guggenheim initiated coverage on August 20, 2026, with a Buy rating and a $9.00 price target. - The positive...
🔴 CalciMedica is trading 5.6% down today after reverse split approval
CalciMedica is trading 5.6% down at $0.58 after shareholders approved a reverse stock split ranging from 1-for-2 to 1-for-10 and expanded the company’s equity...
CalciMedica Stockholders Approve Reverse Stock Split and Incentive Plan Expansion
CalciMedica, Inc. announced that stockholders approved several key proposals at its 2026 Annual Meeting of Stockholders held on August 19, 2026. The approved...
🟢 CalciMedica is trading 11.17% up in pre-market as XBI rises 2.27%
CalciMedica is trading at $0.68, up 11.17% in pre-market, primarily on biotech-sector strength. - No new CalciMedica company-specific announcement was...
🟢 CalciMedica is trading 6% up in pre-market as biotech ETF XBI gains 2.27%
CalciMedica is trading at $0.65, up +6.02%, as a 2.27% pre-market gain in biotech ETF XBI points to sector-wide risk appetite. - No new company-specific...